In addition, cancer patients with chronic myeloid leukemia (CML) were shown to have rare quiescent cells also referred to as Philadelphia chromosome-positive and BCR-ABL-positive cells and these cells were able to resist drug treatment [10,11]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.